Applied Therapeutics, Inc. (APLT)
Current
- (-)
After Hours
Rating Performance
Rating Return
+0.0% vs
Rating Accuracy
0.0% (0 of 0*)
Rating Return
+0.0% vs
Rating Accuracy
0.0% (0 of 0*)
Rating Return
+0.0% vs
Rating Accuracy
0.0% (0 of 0*)
Rating Return
-102.21% vs
Rating Accuracy
0.0% (0 of 4*)
FV Performance
FV Accuracy
0 Hits (0.0% Hit Rate)
FV Avg. Distance
+0.0%
FV Accuracy
0 Hits (0.0% Hit Rate)
FV Avg. Distance
+0.0%
FV Accuracy
0 Hits (0.0% Hit Rate)
FV Avg. Distance
+259.06%
FV Accuracy
0 Hits (0.0% Hit Rate)
FV Avg. Distance
+274.78%
About
CEO
Shoshana Shendelman
Employees
11
Industry
Endocrinology and Metabolism Biopharmaceuticals
Sector
Healthcare
Headquarters
New York
Exchange
NASDAQ
Summary Stats
Market Cap
19.9M
Revenue
-
Net Income
-
EPS
$0.00
Price-to-Earnings
-
Price-to-Book
-
Debt-to-Equity
-
News
Analyst Ratings
Price targets projected by 6 analysts
High
$85.00
Average
$53.00
Low
$35.00
Ratings calculated by 7 analysts
Buy
7
Hold
0
Sell
0
Last Dividend
Amount
-
Dividend Date
-
Frequency
-
Dividend Yield
Earnings
Most Recent Earnings
Last Earnings for Q1 2022
Missed by -$0.05
-$0.88 -6.0%
-0.83
-1.0
Up 12%
Actual vs Estimates
XX
xxx
Upcoming Estimates Unavailable
-
-
-
--